Distal myopathy Markesbery–Griggs type
Distal Myopathy Markesbery–Griggs Type is a rare form of muscular dystrophy, specifically classified under the category of distal myopathies. This condition is characterized by the progressive weakness and atrophy of the muscles, particularly affecting those farthest from the center of the body, such as the hands and feet. The disease was first described by Markesbery and Griggs in the late 20th century, marking a significant contribution to the understanding of muscular dystrophies.
Symptoms[edit | edit source]
The primary symptoms of Distal Myopathy Markesbery–Griggs Type include muscle weakness and wasting in the distal limbs, particularly affecting the lower legs and hands. This can lead to difficulties in walking, gripping, and performing fine motor tasks. Symptoms typically manifest in adulthood and progressively worsen over time. Unlike some other forms of muscular dystrophy, heart and respiratory muscles are usually not affected.
Causes[edit | edit source]
Distal Myopathy Markesbery–Griggs Type is caused by genetic mutations. The exact genetic mutation responsible for this condition has been the subject of ongoing research. It is believed to be inherited in an autosomal dominant manner, meaning that only one copy of the altered gene in each cell is sufficient to cause the disorder.
Diagnosis[edit | edit source]
Diagnosis of Distal Myopathy Markesbery–Griggs Type involves a combination of clinical evaluation, family history, and genetic testing. Muscle biopsy may also be performed to examine the muscle tissue for characteristic changes associated with the disease. Electromyography (EMG) and magnetic resonance imaging (MRI) can be used to assess the extent of muscle involvement and differentiate from other muscular dystrophies.
Treatment[edit | edit source]
There is currently no cure for Distal Myopathy Markesbery–Griggs Type. Treatment focuses on managing symptoms and improving quality of life. Physical therapy and occupational therapy can help maintain muscle strength and flexibility, and assistive devices may be recommended to aid in mobility and daily activities. Regular monitoring by a healthcare team is important to address any complications that may arise.
Prognosis[edit | edit source]
The prognosis for individuals with Distal Myopathy Markesbery–Griggs Type varies. While the condition is progressive, the rate of progression can differ significantly between individuals. Many people with this condition are able to maintain a relatively active lifestyle with appropriate management and support.
Distal myopathy Markesbery–Griggs type Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD